31. Large‐scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa. (1st April 2022) Authors: Navrazhina, K.; Renert‐Yuval, Y.; Frew, J.W.; Grand, D.; Gonzalez, J.; Williams, S.C.; Garcet, S.; Krueger, J.G. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Large‐scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa. (21st October 2021) Authors: Navrazhina, K.; Renert‐Yuval, Y.; Frew, J.W.; Grand, D.; Gonzalez, J.; Williams, S.C.; Garcet, S.; Krueger, J.G. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. New therapeutics for itch in dermatomyositis. (17th September 2018) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. New therapeutics for itch in dermatomyositis. (1st September 2018) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. No evidence that impaired Notch signalling differentiates hidradenitis suppurativa from other inflammatory skin diseases. (1st April 2020) Authors: Frew, J.W.; Navrazhina, K. Journal: British journal of dermatology Issue: Volume 182:Number 4(2020) Page Start: 1042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. No evidence that impaired Notch signalling differentiates hidradenitis suppurativa from other inflammatory skin diseases. (25th November 2019) Authors: Frew, J.W.; Navrazhina, K. Journal: British journal of dermatology Issue: Volume 182:Number 4(2020) Page Start: 1042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Putting nodule counts behind us: hidradenitis suppurativa outcome measures independent of descriptive semantics. (1st April 2020) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 182:Number 4(2020) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Putting nodule counts behind us: hidradenitis suppurativa outcome measures independent of descriptive semantics. (4th September 2019) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 182:Number 4(2020) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease. (31st October 2013) Authors: Tjokrowidjaja, A.; Daniel, B.S.; Frew, J.W.; Sebaratnam, D.F.; Hanna, A.M.; Chee, S.; Dermawan, A.; Wang, C.Q.; Lim, C.; Venugopal, S.S.; Rhodes, L.M.; Welsh, B.; Nijsten, T.; Murrell, D.F. Journal: British journal of dermatology Issue: Volume 169:Number 5(2013:Nov.) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Therapeutic biomarkers in hidradenitis suppurativa: one step closer to the clinic. (15th June 2021) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 185:Number 4(2021) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗